EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
   2.4.99.4 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
1997166 |
Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDP-GlcNAc:Gal beta 3 GalNAc alpha-R (GlcNAc to GalNAc) beta(1-6)-N-acetylglucosaminyltransferase in leukemic cells. |
causal interaction
unassigned |
3
0 |
| 2.4.99.4 | Adenocarcinoma |
7591266 |
Expression and function of alpha 2,3-sialyl- and alpha 1,3/1,4-fucosyltransferases in colon adenocarcinoma cell lines: role in synthesis of E-selectin counter-receptors. |
ongoing research
unassigned |
2
0 |
| 2.4.99.4 | Brain Neoplasms |
7868974 |
Effect of Golgi membrane phospholipid composition on the molecular species of GM3 gangliosides synthesized by rat liver sialyltransferase. |
diagnostic usage
ongoing research
unassigned |
1
3
0 |
| 2.4.99.4 | Neuroblastoma |
7868974 |
Effect of Golgi membrane phospholipid composition on the molecular species of GM3 gangliosides synthesized by rat liver sialyltransferase. |
diagnostic usage
ongoing research
unassigned |
1
3
0 |
| 2.4.99.4 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
8220157 |
Role of aberrant sialylation of chronic myeloid leukemia granulocytes on binding and signal transduction by chemotactic peptides and colony stimulating factors. |
causal interaction
unassigned |
1
0 |
| 2.4.99.4 | Leukemia |
8298305 |
Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase. |
causal interaction
unassigned |
2
0 |
| 2.4.99.4 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
8298305 |
Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase. |
causal interaction
unassigned |
2
0 |
| 2.4.99.4 | Leukemia, Myeloid, Acute |
8298305 |
Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase. |
causal interaction
unassigned |
2
0 |
| 2.4.99.4 | Carcinoma |
9128982 |
alpha-2,3-Sialyltransferase type 3N and alpha-1,3-fucosyltransferase type VII are related to sialyl Lewis(x) synthesis and patient survival from lung carcinoma. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
4
1
1 |
| 2.4.99.4 | Breast Neoplasms |
9751611 |
Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
4
3
0 |
